RACHEL MISCH: Open Payments
NPI 1356088330 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,762 in 60 payments from 16 companies in 2025. Trend: 2023 $2,486 · 2024 $1,242 · 2025 $1,762
Food & beverage: $1,619Education: $143
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $520 |
| Amgen Inc. | 7 | $164 |
| MERZ NORTH AMERICA, INC. | 2 | $162 |
| Janssen Biotech, Inc. | 4 | $150 |
| Novartis Pharmaceuticals Corporation | 6 | $131 |
| REVANCE THERAPEUTICS, INC. | 1 | $130 |
| UCB, Inc. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 4 | $84 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $77 |
| PFIZER INC. | 2 | $58 |
Products named: SKYRIZI, Otezla, BOTOX, Xeomin, TREMFYA, DAXXIFY, Bimzelx, RINVOQ.
Industry payments across FL — which companies pay providers there.
